About this work

Purpose
Capture the annual review — functional status, fluid balance, monitoring bloods, and medication optimisation — and produce a graded report: an NYHA functional status, a four-pillar medication-optimisation status (ACEi/ARB/ARNI, beta-blocker, MRA, SGLT2 inhibitor), a review-completeness grade, and flagged issues, to support the QOF heart-failure register review and prompt escalation where a safety flag is raised.
Specification
Spec-driven: the living domain spec defines the data model, the classification engine, and the flag rules. The same engine grades both the form and the dashboard.
Documentation
Aligned with NICE NG106, NICE QS9, the NYHA classification, and the 2021 ESC heart-failure guidelines. A documentation and status-classification aid, not a diagnosis, and not a substitute for clinical judgement.